The Paving Roll-Up: What Happens When a Public Consolidator Buys Up Your Market

The $17.5 Billion Reactor Loan Program 2026: Westinghouse's Five-Site Bet and How Subcontractors Get on the Prequal List First

Washington just put $17.5 billion in conditional loans behind a plan to build ten large reactors across five sites - the biggest single push to restart American large-reactor construction in a generation. Who has to put up a billion dollars in equity before a shovel moves, which regions get the work, and the prequalification move every civil, concrete, mechanical, and electrical sub should make before the EPCs lock up the bid list.

The Architecture Billings Warning 2026: The Leading Indicator Just Went Negative on Billings, Inquiries, and New Contracts at Once

The construction industry's best 9-to-12-month early warning just flashed red: architecture firm billings fell to their lowest in months, project inquiries slipped below the growth line for the first time in a third of a year, and the value of newly signed design contracts dropped too. What a simultaneous decline across all three signals means for your 2027 nonresidential backlog - and how to plan bids around it now.

Ohio's E-Verify Workforce Integrity Act 2026: The New Compliance Clock Every Construction Employer Just Started — and the Steps to Take Before It Bites

Ohio's 'E-Verify Workforce Integrity Act' will impose new requirements on construction employers, part of a wave of state E-Verify mandates drawing business pushback. With immigration enforcement already tightening craft labor, here's the compliance checklist contractors need now — separate from the labor-shortage headlines.

The Paving Roll-Up: What Happens When a Public Consolidator Buys Up Your Market

A NASDAQ-listed consolidator, Construction Partners (ROAD), is quietly buying the local asphalt and paving contractors across Sunbelt metros — GMJ Paving in Houston, Four Star Paving in Nashville — while posting 44% revenue growth. We break down what changes for the independent contractor-owner when a public roll-up enters your market: pricing power, talent gravity, materials integration, and what it means for your own exit options.

Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast

Novo Nordisk is investing $4.1 billion in a 1.4-million-square-foot, 10-building manufacturing expansion in Clayton, North Carolina to ramp Ozempic and Wegovy production — and BE&K Building Group just landed the build as Design-Builder and Agency Construction Manager across a 56-acre campus. We break down why life-sciences construction is the new megaproject gold rush, how the design-build delivery model changes who wins subcontracts, and how mid-market contractors can position for phased 2027-2